• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清生长分化因子-15及句法评分对急性冠状动脉综合征患者2年预后的影响

Effect of Serum Growth Differentiation Factor-15 and the Syntax Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome.

作者信息

Dominguez-Rodriguez Alberto, Abreu-Gonzalez Pedro, Avanzas Pablo, Consuegra-Sanchez Luciano

机构信息

Hospital Universitario de Canarias, Servicio de Cardiología, Santa Cruz de Tenerife, Spain; Facultad de Ciencias de la Salud, Universidad Europea de Canarias, La Orotava, Santa Cruz de Tenerife, Spain.

Departamento de Ciencias Medicas Básicas (Unidad de Fisiología), Universidad de La Laguna, Santa Cruz de Tenerife, Spain.

出版信息

Am J Cardiol. 2016 May 15;117(10):1569-1574. doi: 10.1016/j.amjcard.2016.02.031. Epub 2016 Mar 2.

DOI:10.1016/j.amjcard.2016.02.031
PMID:27013387
Abstract

Growth differentiation factor-15 (GDF-15) is produced by cardiomyocytes and atherosclerotic lesions under stress conditions, but little is known about its relation with severity and complexity of coronary lesions. The aim of this study was to investigate the association between GDF-15 and the syntax score for risk prediction of major adverse cardiovascular events (MACE) at 2-year follow-up in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS). This is a prospective cohort study of 502 patients with NSTEACS. The syntax score was calculated from baseline coronary angiography. Blood samples were obtained at study entry for the assessment of GDF-15 and high-sensitivity C reactive protein. One hundred and three patients (20.5%) showed MACE at 2-year follow-up. Patients who developed MACE had greater GDF-15 concentrations and syntax score (p <0.001) compared to patients who did not. There was a positive, but moderate, correlation between GDF-15 and syntax score (ρ = 0.45, p <0.0001). On Cox regression analysis, only GDF-15 levels (p <0.001), body mass index (p = 0.04), and syntax score (p <0.001) remained independent predictors of the MACE. The area under the curve of GDF-15 (0.912, 95% confidence interval 0.894 to 0.944) was significantly greater compared to high-sensitivity C reactive protein and syntax score. In conclusion, in patients with NSTEACS, levels of GDF-15 at admission were correlated with the syntax score and independently associated with an increased risk of MACE during 2-year follow-up.

摘要

生长分化因子15(GDF - 15)在应激条件下由心肌细胞和动脉粥样硬化病变产生,但对其与冠状动脉病变严重程度和复杂性的关系知之甚少。本研究旨在探讨非ST段抬高型急性冠状动脉综合征(NSTEACS)患者中,GDF - 15与2年随访时主要不良心血管事件(MACE)风险预测的SYNTAX评分之间的关联。这是一项对502例NSTEACS患者的前瞻性队列研究。SYNTAX评分根据基线冠状动脉造影计算得出。在研究入组时采集血样,用于评估GDF - 15和高敏C反应蛋白。103例患者(20.5%)在2年随访时出现MACE。与未发生MACE的患者相比,发生MACE的患者GDF - 15浓度和SYNTAX评分更高(p <0.001)。GDF - 15与SYNTAX评分之间存在正相关,但相关性中等(ρ = 0.45,p <0.0001)。在Cox回归分析中,只有GDF - 15水平(p <0.001)、体重指数(p = 0.04)和SYNTAX评分(p <0.001)仍然是MACE的独立预测因素。GDF - 15的曲线下面积(0.912,95%置信区间0.894至0.944)显著大于高敏C反应蛋白和SYNTAX评分。总之,在NSTEACS患者中,入院时GDF - 15水平与SYNTAX评分相关,并且在2年随访期间与MACE风险增加独立相关。

相似文献

1
Effect of Serum Growth Differentiation Factor-15 and the Syntax Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome.血清生长分化因子-15及句法评分对急性冠状动脉综合征患者2年预后的影响
Am J Cardiol. 2016 May 15;117(10):1569-1574. doi: 10.1016/j.amjcard.2016.02.031. Epub 2016 Mar 2.
2
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.基因多态性、血小板反应性和 SYNTAX 评分对行经皮冠状动脉介入治疗的非 ST 段抬高型急性冠状动脉综合征患者 1 年临床结局的影响:GEPRESS 研究。
JACC Cardiovasc Interv. 2014 Oct;7(10):1117-27. doi: 10.1016/j.jcin.2014.04.020. Epub 2014 Sep 17.
3
Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.改善急性胸痛患者的长期风险预测:全球急性冠状动脉事件注册(GRACE)风险评分通过选择的非坏死生物标志物得到增强。
Am Heart J. 2010 Jul;160(1):88-94. doi: 10.1016/j.ahj.2010.05.002.
4
Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction.生长分化因子 15 与 ST 段抬高型心肌梗死患者左心室重构的关系。
Am J Cardiol. 2011 Oct 1;108(7):955-8. doi: 10.1016/j.amjcard.2011.05.028. Epub 2011 Jul 23.
5
Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.生长分化因子15用于非ST段抬高型急性冠状动脉综合征患者的长期预后评估:不稳定冠状动脉综合征侵入性与保守治疗(ICTUS)亚研究
Int J Cardiol. 2014 Mar 15;172(2):356-63. doi: 10.1016/j.ijcard.2014.01.025. Epub 2014 Jan 23.
6
Usefulness of Serum Albumin Concentration to Predict High Coronary SYNTAX Score and In-Hospital Mortality in Patients With Acute Coronary Syndrome.血清白蛋白浓度对预测急性冠状动脉综合征患者高冠状动脉SYNTAX评分及院内死亡率的价值
Angiology. 2016 Jan;67(1):34-40. doi: 10.1177/0003319715575220. Epub 2015 Mar 17.
7
Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).冠状动脉严重程度评分和 C 反应蛋白可预测稳定性冠心病患者的主要不良心血管事件(来自台中 CAD 研究)。
Clin Chim Acta. 2015 May 20;445:93-100. doi: 10.1016/j.cca.2015.03.029. Epub 2015 Mar 27.
8
Long-term prognostic value of growth differentiation factor-15 in acute coronary syndromes.生长分化因子-15 在急性冠状动脉综合征中的长期预后价值。
Clin Biochem. 2019 Nov;73:62-69. doi: 10.1016/j.clinbiochem.2019.07.014. Epub 2019 Jul 29.
9
The association between growth differentiation factor 15 and presence and severity of coronary atherosclerosis.生长分化因子15与冠状动脉粥样硬化的存在及严重程度之间的关联。
Adv Med Sci. 2024 Mar;69(1):56-60. doi: 10.1016/j.advms.2024.02.003. Epub 2024 Feb 17.
10
Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.生长分化因子-15水平升高对接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者进行分类的效用,这些患者将从大剂量他汀类药物治疗中获益。
Am J Cardiol. 2017 Sep 1;120(5):747-752. doi: 10.1016/j.amjcard.2017.05.045. Epub 2017 Jun 15.

引用本文的文献

1
Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study.生长分化因子 15 可预测冠心病患者的全因死亡和主要不良心血管事件:一项前瞻性队列研究。
J Thromb Thrombolysis. 2024 Oct;57(7):1109-1121. doi: 10.1007/s11239-024-03019-5. Epub 2024 Jul 28.
2
Association of GDF-15 and Syntax Score in Patient with Acute Myocardial Infarction.GDF-15 与急性心肌梗死患者 Syntax 评分的相关性研究。
Cardiovasc Ther. 2019 Mar 5;2019:9820210. doi: 10.1155/2019/9820210. eCollection 2019.
3
Roles of Growth Differentiation Factor 15 in Atherosclerosis and Coronary Artery Disease.
生长分化因子15在动脉粥样硬化和冠状动脉疾病中的作用
J Am Heart Assoc. 2019 Sep 3;8(17):e012826. doi: 10.1161/JAHA.119.012826. Epub 2019 Aug 21.
4
Prognostic biomarkers in acute coronary syndrome.急性冠状动脉综合征的预后生物标志物。
Ann Transl Med. 2016 Jul;4(13):258. doi: 10.21037/atm.2016.06.36.